| Danielle Erin Stahlbaum, MD | |
|
39901 Traditions Dr, Northville, MI 48168-9493 | |
| (734) 615-3217 | |
| Not Available |
| Full Name | Danielle Erin Stahlbaum |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 39901 Traditions Dr, Northville, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386023851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301506394 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
A large international study conducted by the European Organisation for Research and Treatment of Cancer (EORTC) in collaboration with the National Cancer Institute of Canada (NCIC) Clinical Trials Group demonstrated that the addition of a novel chemotherapy agent, Temozolomide (brand name: Temodal®) to radiation therapy increases survival in patients suffering from glioblastoma, a very aggressive form of a brain tumour.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
A new project to improve asthma in African children has been officially launched at an event in Durban, South Africa.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
› Verified 1 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
A large international study conducted by the European Organisation for Research and Treatment of Cancer (EORTC) in collaboration with the National Cancer Institute of Canada (NCIC) Clinical Trials Group demonstrated that the addition of a novel chemotherapy agent, Temozolomide (brand name: Temodal®) to radiation therapy increases survival in patients suffering from glioblastoma, a very aggressive form of a brain tumour.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
A new project to improve asthma in African children has been officially launched at an event in Durban, South Africa.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Erin Stahlbaum, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Danielle Erin Stahlbaum, MD 39901 Traditions Dr, Northville, MI 48168-9493 Ph: (734) 615-3217 |
News Archive
A large international study conducted by the European Organisation for Research and Treatment of Cancer (EORTC) in collaboration with the National Cancer Institute of Canada (NCIC) Clinical Trials Group demonstrated that the addition of a novel chemotherapy agent, Temozolomide (brand name: Temodal®) to radiation therapy increases survival in patients suffering from glioblastoma, a very aggressive form of a brain tumour.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
A new project to improve asthma in African children has been officially launched at an event in Durban, South Africa.
Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.
› Verified 1 days ago
Borko Nojkov, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Drive, Suite 210, Northville, MI 48168 Phone: 888-229-7408 | |
Dr. Jahangir Mohtadi, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 21301 Woodhill Dr, Northville, MI 48167 Phone: 248-477-8009 | |
Denise H Zao, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Drive, Suite 210, Northville, MI 48168 Phone: 248-888-9000 | |
Keerthi Rekha Karamched, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Dr, Suite 210, Northville, MI 48168 Phone: 248-305-4400 | |
Dr. Keith Brian Naylor, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Drive, Suite 210, Northville, MI 48168 Phone: 888-229-7408 | |
Kimberly Nicole Harer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Drive, Suite 210, Northville, MI 48168 Phone: 888-229-7408 | |
Tannaz Guivatchian, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 39901 Traditions Dr, Suite 210, Northville, MI 48168 Phone: 888-229-7408 |